Neuralink Sees $1 Billion of Revenue by 2031 in Vast Expansion

Elon Musk’s brain implant company Neuralink Corp. expects to put its chips in 20,000 people a year by 2031, generating at least $1 billion in annual revenue, in a major ramp up of its work to treat disease and gain unprecedented access to the human mind, according to documents reviewed by Bloomberg.

Within six years the company also plans to have about five large clinics in operation, with at least three versions of its device available, according to a recent presentation shown to investors. One version, Telepathy, is for enabling communication between the brain and machines; another, Blindsight, is aimed at giving vision to blind people; and a third, Deep, would treat tremors and Parkinson’s disease.